JWH-201 is a synthetic cannabinoid that belongs to a class of compounds known for their psychoactive effects, often mimicking the action of natural cannabinoids found in cannabis. It was developed by Dr. John W. Huffman and is characterized by its ability to bind to cannabinoid receptors in the brain, particularly CB1 and CB2 receptors. JWH-201 is typically encountered as a white crystalline powder and is often used in research settings to study the endocannabinoid system and its potential therapeutic applications. Its chemical structure includes a naphthyl group, which contributes to its potency and selectivity for cannabinoid receptors. As a synthetic compound, JWH-201 has raised concerns regarding safety, legality, and potential for abuse, leading to its classification as a controlled substance in many jurisdictions. Research on JWH-201 has highlighted its effects on mood, perception, and cognition, but it also poses risks of adverse effects similar to those associated with other synthetic cannabinoids.

JWH-201

864445-47-6: JWH-201 is a synthetic cannabinoid that belongs to a class of compounds known for their psychoactive effects, often mimicking the action of natural cannabinoids found in cannabis. It was developed by Dr. John W. Huffman and is characterized by its ability to bind to cannabinoid receptors in the brain, particularly CB1 and CB2 receptors. JWH-201 is typically encountered as a white crystalline powder and is often used in research settings to study the endocannabinoid system and its potential therapeutic applications. Its chemical structure includes a naphthyl group, which contributes to its potency and selectivity for cannabinoid receptors. As a synthetic compound, JWH-201 has raised concerns regarding safety, legality, and potential for abuse, leading to its classification as a controlled substance in many jurisdictions. Research on JWH-201 has highlighted its effects on mood, perception, and cognition, but it also poses risks of adverse effects similar to those associated with other synthetic cannabinoids.

JWH-201 is a synthetic cannabinoid that binds to the CB1 receptor. It has structural features similar to other cannabinoids, such as ab-fubinaca, adb-fubinaca, and tetrahydrocannabinol. JWH-201 is not metabolized by cytochrome P450 enzymes and is excreted in urine unchanged. This synthetic cannabinoid has been shown to have a high affinity for the CB1 receptor and a low affinity for the CB2 receptor. JWH-201 has been shown to be utilizable and can be used in chemical research. The compound also has electron ionization characteristics that are suitable for chemical analyses.

CAS 864445-47-6

JWH-201

JWH-201

Ref: 3D-PJB44547